Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

VistaGen Therapeutics Inc VSTA

Sector: Healthcare | Sub-Sector: Biotechnology

VistaGen Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops and commercializes product candidates for patients with depression, other diseases and disorders related to the central nervous system (CNS), and cancer.
Price: $11.00 | Change: $0.00 | %Change: 0.00%
Volume: 400 | Day High/Low: 11.00/10.25 | 52 Week High/Low: 16.50/3.16
View modes: 
0 stars

VistaGen Therapeutics, Inc. (VSTA) Aligned with World Health

VistaGen Therapeutics, Inc. (VSTA) Aligned with World Health Organization’s Global Call for Scaled-Up Response to Mental Disorders Millions of people around the world suffer from depression, which...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Utilizing Stem Cell Techn

VistaGen Therapeutics, Inc. (VSTA) Utilizing Stem Cell Technology to Improve Predictability in Clinical Trials Unexpected cardiotoxicity, which damages the heart muscles, is among the most prevalent...read more
0 stars

VistaGen Therapeutics, Inc.’s (VSTA) Next-Gen CNS Drug Candi

VistaGen Therapeutics, Inc.’s (VSTA) Next-Gen CNS Drug Candidate Poised for Revolutionary Breakthrough VistaGen Therapeutics was founded in the late 1990s by a team of scientists believing that...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) AV-101 Seen as Safe Ketam

VistaGen Therapeutics, Inc. (VSTA) AV-101 Seen as Safe Ketamine Alternative for Major Depressive Disorder According to a report published in September of 2014 by Transparency Market Research on...read more
0 stars

Economic Impacts of Depression Impacts are Staggering – Vist

Economic Impacts of Depression Impacts are Staggering – VistaGen Therapeutics (VSTA) Aggressively Pursues Treatment If you think depression only affects the individual suffering from the disorder, or...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Working to Revolutionize

VistaGen Therapeutics, Inc. (VSTA) Working to Revolutionize Depression Treatment Ketamine has been shown as an extremely effective treatment for patients suffering from major depressive disorder (MDD...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Partners with NIH in its

VistaGen Therapeutics, Inc. (VSTA) Partners with NIH in its Sponsored Phase 2 Study of Orally-Active AV-101 in MDD VistaGen Therapeutics, a clinical-stage biopharmaceutical company focused on...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Welcomes Dr. Gerard Sanac

VistaGen Therapeutics, Inc. (VSTA) Welcomes Dr. Gerard Sanacora to Clinical and Scientific Advisory Board VistaGen Therapeutics, a clinical-stage biopharmaceutical company developing innovative...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) – Applying Stem Cell Tech

VistaGen Therapeutics, Inc. (VSTA) – Applying Stem Cell Technology toward Drug Rescue and New Generation Drug Toxicity Screening Believing that better cells lead to better medicine, VistaGen...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Making Impressive Strides

VistaGen Therapeutics, Inc. (VSTA) Making Impressive Strides in Curbing Costs Associated with Depression Treatments Since inception, VistaGen Therapeutics has focused on creating human cell-based...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) is Optimistic About Its D

VistaGen Therapeutics, Inc. (VSTA) is Optimistic About Its Depression Medicine Depression, as many of us know, is more than just a sad or melancholy mood. It’s more than just having “the blues...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) – Developing Leading-Edge

VistaGen Therapeutics, Inc. (VSTA) – Developing Leading-Edge Biotechnology Offerings VistaGen Therapeutics is bringing human biology to the front end of the long and costly drug development process...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) AV-101 Rivals Ketamine an

VistaGen Therapeutics, Inc. (VSTA) AV-101 Rivals Ketamine and Other Next-Gen Anti-depressants On the street ketamine is referred to as “Special K,” a drug popular in the party scene because of its...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Embarking on Key Stage 2

VistaGen Therapeutics, Inc. (VSTA) Embarking on Key Stage 2 Clinical Trial of Potential Breakthrough Major Depression Therapy With the very public suicide of actor/comedian Robin Williams recently...read more
0 stars

VistaGen Therapeutics Inc. (VSTA) AV-101 Poised to Emerge as

VistaGen Therapeutics Inc. (VSTA) AV-101 Poised to Emerge as a Leading Candidate in Multibillion Dollar Global Antidepressant Market Depression affects nearly 7% of all adults in the U.S. and over...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Authorizes Letter of Inte

VistaGen Therapeutics, Inc. (VSTA) Authorizes Letter of Intent with NIMH for NIH-Sponsored Phase 2 Study of AV-101 in Major Depressive Disorder VistaGen signed a Letter of Intent to enter into a...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Sees AV-101 as Potential

VistaGen Therapeutics, Inc. (VSTA) Sees AV-101 as Potential Breakthrough Drug for Major Depressive Disorder Potential to Address Major U.S. and Global Need It’s one of the single most sought-after...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Receives Notice of Allowa

VistaGen Therapeutics, Inc. (VSTA) Receives Notice of Allowance for Stem Cell Technology Today before the opening bell, VistaGen Therapeutics announced its reception of a Notice of Allowance from the...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Provides Reverse Stock Sp

VistaGen Therapeutics, Inc. (VSTA) Provides Reverse Stock Split FAQs Last week, VistaGen Therapeutics implemented a 1-for-20 reverse split of its common stock. As a result, the number of shares of...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Announces New Agreement

VistaGen Therapeutics, Inc. (VSTA) Announces New Agreement with Largest Shareholder In an 8-K filed with the SEC today, VistaGen Therapeutics announced that Platinum Long Term Growth VII, LLC, the...read more